Zobrazeno 1 - 10
of 1 692
pro vyhledávání: '"portopulmonary hypertension"'
Publikováno v:
Journal of Anesthesia, Analgesia and Critical Care, Vol 4, Iss 1, Pp 1-15 (2024)
Abstract Cardiovascular complications are common in patients with severe liver disease and are an important cause of peri-operative and post-transplant morbidity and mortality. Cirrhotic cardiomyopathy (CCM), often found in advanced liver disease, is
Externí odkaz:
https://doaj.org/article/ded3bde9d84f4f5aa79283bb07e8d1bb
Publikováno v:
Jichu yixue yu linchuang, Vol 44, Iss 8, Pp 1068-1073 (2024)
Portopulmonary hypertension (PoPH) represents one of complications occurred in patients with portal hypertension, which is characterized by high mortality rate and poor prognosis. The pathogenesis of PoPH remains unclear; it is believed to involve a
Externí odkaz:
https://doaj.org/article/d1b48a88502a4b6590b49ebcac0d04d2
Autor:
Thierry Thevenot, Sarah Raevens, Avinash Aujayeb, Bubu A. Banini, Jean François D. Cadranel, Hilary M. DuBrock
Publikováno v:
Exploration of Digestive Diseases, Vol 3, Iss 4, Pp 301-325 (2024)
Patients with advanced chronic liver disease can develop specific pulmonary complications related or unrelated to pre-existing lung disease. The three major pulmonary complications in this patient population include hepatopulmonary syndrome (HPS), po
Externí odkaz:
https://doaj.org/article/e3bf5bff454a40aab4d060f4d97e815e
Publikováno v:
Медицина неотложных состояний, Vol 20, Iss 3, Pp 146-158 (2024)
Portopulmonary hypertension is defined as the development of pulmonary hypertension secondary to portal one. Its exact prevalence is difficult to determine due to the lack of routine screening in patients with portal hypertension. Hemodynamic changes
Externí odkaz:
https://doaj.org/article/6e5df723212a4d2fb2834ab8092c8044
Autor:
Takatoyo Kiko, Ryotaro Asano, Hiroyuki Endo, Naruhiro Nishi, Hiroya Hayashi, Jin Ueda, Tatsuo Aoki, Akihiro Tsuji, Takeshi Ogo
Publikováno v:
International Journal of Cardiology. Cardiovascular Risk and Prevention, Vol 22, Iss , Pp 200294- (2024)
Background: Limited data exists on upfront combination therapy for portopulmonary hypertension. We evaluated the clinical efficacy, long-term outcomes, and safety of upfront combination therapy in patients with portopulmonary hypertension. Methods: W
Externí odkaz:
https://doaj.org/article/7f0cd0e868db47bea029bdf2432c5329
Autor:
Nick H. Kim, Kelly M. Chin, Vallerie V. McLaughlin, Hilary DuBrock, Ricardo Restrepo-Jaramillo, Zeenat Safdar, Gwen MacDonald, Nicolas Martin, Daniel Rosenberg, Maria Solonets, Richard Channick
Publikováno v:
Pulmonary Therapy, Vol 10, Iss 1, Pp 85-107 (2024)
Abstract Introduction Portopulmonary hypertension (PoPH) carries a worse prognosis than other forms of pulmonary arterial hypertension (PAH). Data regarding use of PAH-specific therapies in patients with PoPH are sparse as they are usually excluded f
Externí odkaz:
https://doaj.org/article/d2d527f021da4bc98cd27bae7d4bdc4e
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 23, Iss 3 (2024)
Pulmonary arterial hypertension (PAH) associated with portal hypertension, or portopulmonary hypertension, is a severe, life-threatening complication of portal hypertension and/or portocaval shunt surgery. Congenital portocaval shunts (CPSSs) are rar
Externí odkaz:
https://doaj.org/article/3677d29f1b6045c2b43e7a6ee5907895
Autor:
Muli Yaman, Syifa Mustika
Publikováno v:
Clinical and Research Journal in Internal Medicine, Vol 4, Iss 2, Pp 470-480 (2023)
Regardless of preexisting lung illness, patients suffering from liver cirrhosis, especially decompensated liver cirrhosis can develop distinct pulmonary complications. Liver cirrhosis patients should be assessed for hepatopulmonary syndrome (HPS), po
Externí odkaz:
https://doaj.org/article/3e842d5bf25e40e298db8a8be45a0137
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shun‐Ichi Wakabayashi, Satoru Joshita, Kazuhiro Kimura, Hirohiko Motoki, Taiki Okumura, Hiroyuki Kobayashi, Yuki Yamashita, Ayumi Sugiura, Tomoo Yamazaki, Takefumi Kimura, Koichiro Kuwahara, Takeji Umemura
Publikováno v:
JGH Open, Vol 7, Iss 8, Pp 527-536 (2023)
Abstract Background and Aim As the exact prevalence of portopulmonary hypertension (PoPH) and the etiology of chronic liver disease (CLD) remain unknown, the present study aimed to clarify these points in Japanese patients with CLD using symptom‐ba
Externí odkaz:
https://doaj.org/article/9e32efad0ee4408f9ea877da2088beab